Sign up for Pharmacy U e-newsletter  |
Join our community |
|
| Sign up for Pharmacy U e-newsletter |
All posts tagged Shelley Diamond
03
AugMeal replacement products and Type 2 diabetes
Comments Off on Meal replacement products and Type 2 diabetes
The 2013 Canadian Diabetes Association’s Clinical Practice Guidelines included the use of meal replacement products for the first time. Now they are seen as a possible useful weight management tool.
Read more
13
JulDiabetic nephropathy – how you can help your patients
Comments Off on Diabetic nephropathy – how you can help your patients
The kidneys have millions of blood vessels, and since diabetes is really a ‘disease of the blood vessels’, this means the kidneys are very susceptible to harm. Read more
01
JunProblems that are more than skin deep for patients with diabetes
Comments Off on Problems that are more than skin deep for patients with diabetes
The skin offers a window to what is happening inside the body, so changes to the skin may signal a more serious health problem, often serving as a marker for underlying internal disease. Read more
12
FebCreating the parent-friendly pharmacy
Comments Off on Creating the parent-friendly pharmacy
Who is your audience as a pharmacist? New mothers in their 40s. Extended families. You may even be prescribing vet meds for your patients' animals. How do you create a parent-friendly pharmacy for all types of parents and families? Read more
25
AprPharmacotherapy for managing painful diabetic neuropathy
Comments Off on Pharmacotherapy for managing painful diabetic neuropathy
Diabetic neuropathies are a disabling condition and the most common form has been estimated to occur in at least 20% of people with type 1 diabetes after 20 years of disease duration, and 10-15% of newly diagnosed patients with type 2 diabetes, increasing to 50% after.
Read more
18
NovTwo for the price of one – Cardioprotection and glucose-lowering!
Comments Off on Two for the price of one – Cardioprotection and glucose-lowering!
Two landmark studies have made an impact on what recommendations we will make for pharmacologic management of patients with type 2 diabetes. Read more
